Federal Regulation

You are here

DOT Rule 49 CFR Part 40 Section 40.87

Updated: Monday, January 1, 2018

Subpart F - Drug Testing Laboratories

§ 40.87  What are the cutoff concentrations for drug tests?
 
(a) As a laboratory, you must use the cutoff concentrations displayed in the following table for initial and confirmatory drug tests. All cutoff concentrations are expressed in nanograms per milliliter (ng/mL).   The table follows:
Cutoff Concentrations for Drug Tests

Initial test analyte

Initial test cutoff1

Confirmatory test analyte

Confirmatory test cutoff concentration

Marijuana metabolites (THCA)2

50 ng/mL3

THCA

15 ng/mL.

Cocaine metabolite (Benzoylecgonine)

150 ng/mL3

Benzoylecgonine

100 ng/mL.

Codeine/
Morphine

2000 ng/mL

Codeine
Morphine

2000 ng/mL.
2000 ng/mL.

Hydrocodone/
Hydromorphone

300 ng/mL

Hydrocodone
Hydromorphone

100 ng/mL.
100 ng/mL.

Oxycodone/
Oxymorphone

100 ng/mL

Oxycodone
Oxymorphone

100 ng/mL.
100 ng/mL.

6-Acetylmorphine

10 ng/mL

6-Acetylmorphine

10 ng/mL.

Phencyclidine

25 ng/mL

Phencyclidine

25 ng/mL.

Amphetamine/
Methamphetamine

500 ng/mL

Amphetamine
Methamphetamine

250 ng/mL.
250 ng/mL.

MDMA4/MDA5

500 ng/mL

MDMA
MDA

250 ng/mL.
250 ng/mL.

1For grouped analytes (i.e., two or more analytes that are in the same drug class and have the same initial test cutoff):

Immunoassay: The test must be calibrated with one analyte from the group identified as the target analyte.  The cross-reactivity of the immunoassay to the other analyte(s) within the group must be 80 percent or greater; if not, separate immunoassays must be used for the analytes within the group.

Alternate technology: Either one analyte or all analytes from the group must be used for calibration, depending on the technology.  At least one analyte within the group must have a concentration equal to or greater than the initial test cutoff or, alternatively, the sum of the analytes present (i.e., equal to or greater than the laboratory’s validated limit of quantification) must be equal to or greater than the initial test cutoff.
 
2An immunoassay must be calibrated with the target analyte, ∆-9-tetrahydrocannabinol-9-carboxylic acid (THCA).
3Alternate technology (THCA and Benzoylecgonine): When using an alternate technology initial test for the specific target analytes of THCA and Benzoylecgonine, the laboratory must use the same cutoff for the initial and confirmatory tests (i.e., 15 ng/mL for THCA and 100ng/mL for Benzoylecgonine).
4Methylenedioxymethamphetamine (MDMA).
5Methylenedioxyamphetamine (MDA).
 
(b) On an initial drug test, you must report a result below the cutoff concentration as negative. If the result is at or above the cutoff concentration, you must conduct a confirmation test.
 
(c) On a confirmation drug test, you must report a result below the cutoff concentration as negative and a result at or above the cutoff concentration as confirmed positive.
 
(d) You must report quantitative values for morphine or codeine at 15,000 ng/mL or above.
 
[65 FR 79526, Dec. 19, 2000, as amended at 75 FR 49862, August 16, 2010; 77 FR 26473, May 4, 2012; 82 FR 52244, November 13, 2017]
 
Submit Feedback >